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Summary. To study numerical changes in intestinal
macrophages and variations in cytokine production by
immune cells in the intestine, conventional C57BL/6J
mice were orally infected with the Rocky Mountain
Laboratory strain of scrapie. Animals were sacrificed at
different timepoints, and samples were taken and
processed by routine methods for morphological and
immunohistochemical analysis. The results point to a
possible role for macrophages in the uptake and
transport of the infective agent to Peyer’s patches. The
observed increase in macrophage numbers in
subepithelial sites, taken in conjunction with a drop in
tumour necrosis factor-α production at these sites,
suggests a possible secretory inhibition that could be
induced by the disease-associated prion protein (PrPd).
On the other hand, cytokine dynamics indicated the
presence of an impaired Th1-Th2 cell mediated
response, which could facilitate the spread of PrPd to the
central nervous system. Further research is required to
confirm these hypotheses.
Key words: Scrapie, Cytokines, Immune response,
Gut-associated lymphoid tissues, Pathology
Introduction
Transmissible spongiform encephalopathies (TSEs)
constitute a group of fatal neurodegenerative diseases
caused by the accumulation of a conformationally-
changed prion protein. This change results from a
conversion of part of the α-helix structure into ß-sheet
secondary structures (Prusiner, 1998). Animal TSEs
include scrapie in sheep and goats, and bovine
spongiform encephalopathy or chronic wasting disease,
whereas Creutzfeldt-Jakob disease and its variant,
Gerstmann-Sträussler-Scheinker syndrome, familial fatal
insomnia and kuru affect human beings. The
accumulation of this ß-sheet-rich isoform or PrPd in the
central nervous system (CNS) is responsible for the most
common pathologies in these diseases, including glial
activation, neuronal loss, amyloidal aggregation, and
spongiform changes in neurons and neuropil (Chesebro,
2003), which give rise to the neural clinical signs typical
of TSEs.
It is commonly accepted that, after a natural or
experimental oral infection, PrPd accumulates in cells of
the lymphoreticular system, such as tingible body
macrophages and follicular dendritic cells, in gut-
associated lymphoid tissue (GALT) and in mesenteric
lymphnodes, before spreading to the CNS through
peripheral nerves in the intestinal wall (Beekes and
McBride, 2000; Van Keulen et al., 2000; Jeffrey et al.,
2006). From the CNS, PrPd can subsequently reach
other tissues, e.g. muscles, by centrifugal diffusion
(Beekes and McBride, 2007). Despite the importance of
understanding the pathogenesis of TSEs, and despite
their public-health significance, few in vivo studies have
focused on the mechanisms of these diseases at natural
entry sites (González et al., 2005; Glaysher and Mabbott,
2007; Raymond et al., 2007; Krüger et al., 2009). 
For years, the absence of an overt inflammatory
response was a commonly-accepted feature of prion
diseases. Currently, however, inflammation of neural
tissues, albeit an atypical response, is regarded as a
cardinal sign of TSEs (Perry et al., 2002; Thackray et al.,
2004), and a role for cytokines and inflammatory
mediators in the neural pathogenesis of prion diseases
has been proposed by a number of authors (Campbell et
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al., 1994; Williams et al., 1994, 1997; Giese et al., 1998;
Peyrin et al., 1999; Veerhuis et al., 2002; Thackray et al.,
2004). However, despite the findings reported for neural
tissues, comparatively little attention has been paid to
the role of chemical mediators produced by intestinal
macrophages, a major immunocompetent-cell population
involved in mucosal immunity against foreign antigens.
In addition to their role in the clearance of cell debris,
intestinal macrophages play an important part in the
initiation of inflammation. Moreover, intestinal
macrophages and follicular dendritic cells are also
responsible for antigen-presenting processes and for the
onset of the local immune response through the
liberation of various chemical mediators (Platt and
Mowat, 2008; Rescigno et al., 2008). Strikingly little
appears to be known about the role of these chemical
mediators at the entry sites for TSEs, in spite of the
importance of the intestine and GALT as defence
mechanisms against oral pathogens. 
The purpose of this study was to evaluate the spatial
and temporal relationship between the presence and
distribution of PrPd in GALT and the quantitative
changes and biosynthetic activation of intestinal
macrophages and other immune cells in this location in
an experimental murine model, in order to ascertain the
local immune response and to throw light on the
pathogenesis of prion diseases.
Materials and methods
Animals
A hundred and fifty conventional healthy female
C57BL/6J mice, aged 4 to 6 weeks, and weighing
approximately 18 g, were used in this study. Animals
were housed according to the European Community
guidelines on animal scientific research. 
PrPd and control inocula
Twelve Rocky Mountain Laboratory (RML) mouse
brains, previously confirmed positive, were supplied by
the Centro de Investigación en Sanidad Animal (CISA-
INIA, Valdeolmos, Madrid, Spain). Brains were pooled
and diluted 1:10 in a commercial lipoid emulsion to be
used as infective inoculum. Twelve normal mouse brains
were pooled and diluted as above to inoculate mock
mice.
Inoculation and monitoring
In order to better reproduce the natural route of
infection of TSEs, one hundred and two 24-hour-fasted
mice were individually placed and orally fed with 300 µl
of infective brain homogenate through an Eppendorf
tube. After fully consuming the homogenate, mice were
housed in batches of 6 until sacrifice. As negative
controls, 4 groups of 6 mice were fed as described with
300 µl of normal brain homogenate (control group 1)
and 4 other groups of 6 mice were not inoculated
(control group 2). To evaluate clinical signs appearing
after inoculation, mice were observed weekly and their
neurological status, loss of appetite and postural
disorders were assessed. 
Sacrifice, necropsy and specimen processing
PrPd-inoculated animals were sacrificed by cervical
dislocation in batches of 6 at 15, 35, 45, 60, 75, 90, 105,
120, 150, 180, 210, 240 and 270 days post-inoculation
(dpi). Mice originally designed to be killed at 300, 350
and 400 dpi were all sacrificed between 270 and 300
days for ethical reasons. Normal brain-inoculated
animals (NBI) and non-inoculated animals (NI) were
also sacrificed in batches of 6 at 0, 35, 90 and 270 dpi, in
order to cover the whole experimental period. Samples
from the distal small intestine – including Peyer’s
patches (PPs) –, mesenteric lymphnodes and brain were
taken and fixed for 24 hours in 10% buffered formalin
solution (pH 7.2) and zinc salt fixative. Subsequently,
samples were dehydrated through a graded series of
alcohol to xylol and routinely embedded in paraffin-wax
for histopathological and immunohistochemical
examination. 
Additionally, samples from the distal small intestine
were taken and fixed in 2.5% glutaraldehyde (0.1 M) in
phosphate buffer saline (pH 7.2), postfixed in 2%
osmium tetroxide, dehydrated in acetone and embedded
in epoxyresins for ultrastructural analysis.
Histopathological, ultrastructural and immunohisto-
chemical analyses
For histopathological analysis, 5-µm wax-embedded
sections of 10% buffered formalin solution-fixed tissues
from the distal small intestine were cut and stained with
hematoxylin and eosin. Samples were then evaluated
through a light microscope. 
For ultrastructural examination, 50-nm sections of
2.5% glutaraldehyde-fixed tissues from the distal small
intestine were counterstained with uranyl acetate and
lead citrate, and viewed through a transmission electron
microscope. 
For immunohistochemical analysis, the avidin-
biotin-peroxidase complex method was used to
immunolabel the different antigens. To characterize the
evolution and dynamics of the disease among the
different target organs, PrPd was demonstrated on 3-µm
sections of 10% buffered formalin-fixed samples from
the distal small intestine, mesenteric lymphnodes and
brain using the polyclonal antibody Rb482. This
antibody reacts with the 221-233 residues of the bovine
PrP. Heat epitope-retrieval treatment was performed by
citrated autoclaving (pH 6.1). Brain sections from
previously scrapie positive-confirmed mice were used as
positive control for Rb482 antibody. To characterize the
local immune response at the entry site, the
identification of macrophage populations (Mac-3) and
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cells producing chemical mediators (TNF-α, IL-1α, IL-
6, IL-10 and IFN-γ) was carried out on 3-µm sections of
zinc salt-fixed distal small intestine samples. No epitope-
retrieval treatments were needed for these antibodies.
Details for primary antibodies used, including dilutions
and antigen-retrieval methods, are summarized in Table
1. 
Tissue sections from PrPd-inoculated animals, in
which the specific primary antibodies were replaced by
rabbit or mouse non-immune serum and Tris Buffer
Saline-Tween 20, were used as negative controls.
Samples from the non-inoculated animals and normal-
brain-inoculated animals were also used as negative
controls.
Cell counts
The presence of reactive cells against Rb482
antibody was evaluated in one 10% formalin-fixed
section of distal small intestine, mesenteric lymphnodes
and brain per animal –six per timepoint – and was
expressed semiquantitatively as follows: 0, none; 1,
scarce; 2, moderate; 3, abundant. For Mac-3, TNF-α, IL-
1α, IL-6, IL-10 and IFN-γ antibodies, one zinc salt-fixed
section of distal small intestine per animal –six per
timepoint – was selected and cell counts were made in
25 consecutive areas of 0.2 mm2. Counts were made
separately in epithelium, lamina propria/submucosa and
Peyer´s patches. Cells were distinguished by virtue of
their location, size and morphological features, and
distribution was expressed as cells per 0.2 mm2.
Statistical analysis
Statistical analysis was performed with a specific
software program. Data on immunopositive cells were
assessed to calculate mean and standard deviation (SD).
Differences between control-group values (NI, non
inoculated and NBI, normal brain inoculated at 0, 35, 90
and 270 dpi respectively) and inoculated-animal values
in each timepoint were tested using the unpaired t-test
Welch corrected (for Gaussian distributions) and the
Mann-Whitney’s U-test (for non-parametric
distributions). Different significance values of P were
considered (*, P<0.05; **, P<0.01 and ***, P<0.001 for
unpaired t-test and †, P<0.05; ††, P<0.01 and †††,
P<0.001 for Mann-Whitney’s-U test). 
Results
Clinical signs, gross lesions and morphological changes
PrPd-infected mice showed typical signs of the
disease at 270 dpi, consisting of stagger, arched back and
erected tail and hair. As progression of the disease was
evident at this timepoint, the remaining animals (mice
originally designed to be killed at 300, 350 and 400 dpi)
were sacrificed for ethical reasons between 270 and 300
dpi and sample collection was halted. No significant
gross lesions were found in infected animal necropsies.
Control animals showed neither clinical signs nor gross
lesions throughout the experiment.
Morphological study was performed on distal small
intestine samples. Significant structural changes were
not observed in infected mice at any timepoint evaluated
in the histopathological study. However, ultrastructural
analysis revealed the presence of numerous fibrillar
protein deposits, ranging between 15 and 20 nm in
thickness, in enterocyte and intraepithelial macrophage
cytoplasms, giving rise to a higher electrondensity of
these cells (Fig. 1A-C). This finding was observed from
the start of the experiment and was interpreted as a
disorganization of the microtubule network. Finally,
normal brain-inoculated animals (control group 1) and
non-inoculated animals (control group 2) developed
neither structural nor ultrastructural lesions.
PrPd distribution
Immunohistochemical analysis was performed using
the Rb482 antibody. Identification of the different cell
types labelling to PrPd was based on morphological
criteria. PrPd was detected in the form of large
intracytoplasmic deposits in tingible body macrophages;
these cells appeared larger than normal, with bean-
shaped nuclei and abundant cytoplasm containing
phagocytized cell debris (tingible bodies). Moreover,
granular depositions resembling reticular structures were
observed in follicular dendritic cells; these cell types
were located inside lymphoid follicles displaying oval to
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Table 1. Details of the primary antibodies used in the immunohistochemical study.
Antibody (clone) Antigen Type Dilutionc Antigen-retrieval method Source
Rb482 PrP Poa 1:2000 Citrated autoclavingd Veterinary Laboratories Agency
M3/84 Mac-3 Mob 1 :100 None BD Pharmingen
XT3 TNF-α Po 1 :100 None Pierce Endogen
IL8A-H12 IL-1α Po 1 :100 None Pierce Endogen
MP5-20F3 IL-6 Mo 1 :100 None AbD Serotec
JES5-2A5 IL-10 Mo 1 :100 None AbD Serotec
RMMG-1 IFN-γ Mo 1 :100 None Calbiochem
a: Polyclonal; b: Monoclonal; c: In Tris buffer saline-Tween 20; d: In 10 mM citrate buffer, pH 6.1, for 30 min at 121 ºC.
round nuclei and thick cytoplasmic projections
(dendrites). 
The results indicated an increase in the presence of
PrPd (Fig. 1D-F) in tingible body macrophages and
follicular dendritic cells within lymphoid follicles in the
PPs of infected mice from 60 dpi, peaking at 180 dpi and
decreasing slightly until the end of the experiment (Table
2). PrPd was also detected in tingible body macrophages
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Fig. 1. Ultrastructural findings and immunohistochemical detection of PrPd in the different structures evaluated. A. Presence of abnormal fibrilar protein
deposits inside an enterocyte. Note the higher electrondensity of this epithelial cell (Transmission electron microscopy (TEM), 45 dpi, Bar: 2 µm). B.
Detail of the previous image at higher magnification. Observe the 15-20 nm thickness fibrils distributed by the cytoplasm (arrow, TEM, 45 dpi, Bar: 500
nm). C. Same proteins in the cytoplasm of an intraepithelial macrophage (arrow, TEM, 45 dpi, Bar: 500 nm). D. PrPd accumulation inside lymphoid
follicle cells of PPs (Immunohistochemistry (IHC), 120 dpi, Bar: 10 µm). E. Positive reaction against the pathogenic prion inside PPs (IHC, 120 dpi, Bar:
100 µm). F. Highest detection of pathogenic prion protein in PPs (IHC, 180 dpi, Bar: 100 µm). G, Presence of PrPd inside lymphoid follicles of
mesenteric lymphnodes (IHC, 120 dpi, Bar: 25 µm). H, Positive immunoreaction against PrPd in lymphoid follicles of mesenteric lymphnodes (IHC, 180
dpi, Bar: 100 µm). I. Detail of the highest detection of the pathogenic prion protein in a lymphoid follicle of mesenteric lymphnodes (IHC, 180 dpi, Bar:
25 µm). J. Myenteric nervous plexus showing immunoreactivity against PrPd (IHC, 270 dpi, Bar: 25 µm). K. Granular and diffuse accumulation of PrPd
in the brain neuropil (IHC, 180 dpi, Bar: 50 µm). L. Typical pathogenic prion protein rosettes observed in the brain neuropil (IHC, 180 dpi, Bar: 25 µm).
and follicular dendritic cells located within the lymphoid
follicles of mesenteric lymphnodes from 60 dpi (Fig.
1G-I). PrPd could not be demonstrated either in
intestinal lymphoid aggregates or in epithelial cells. In
gut myoenteric nervous plexus located between the two
layers of muscular tissue, PrPd was detected as fine,
punctate, intracellular aggregates from 120 dpi onwards
(Fig. 1J). In brain sections, PrPd was observed as a
diffuse granular deposition in the neuropil from 180 dpi
(Fig. 1K,L). Typical PrPd aggregates were also found
occasionally in brain tissues. Sequential distribution of
PrPd in the evaluated tissues, together with the
appearance of clinical signs, is summarized in Table 3.
No PrPd was detected in the intestine, mesenteric
lymphnodes, myoenteric nerve plexus or brain of
negative control groups.
Changes in intestinal macrophage populations
Mac-3 antibody recognized macrophages and
dendritic cells. However, only large cells with abundant
cytoplasm and vesicular nuclei, morphologically
identified as macrophages, were counted. 
An increase in the number of Mac-3-positive
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Fig. 2. Immunohistochemical study of macrophage population in
epithelium, lamina propria/submucosa (LP/SM) and Peyer´s patches (PPs)
of inoculated animals. A. Reactive macrophages immunodetection
infiltrating the intestinal epithelium (IHC, 15 dpi, Bar: 50 µm). B. Presence
of a number of macrophages in intestinal submucosal locations (IHC, 210
dpi, Bar: 50 µm). C. Presence of Mac-3 reactive macrophages distributed
inside PPs. Observe the engulfed cell debris in the cytoplasm of these
cells (IHC, 120 dpi, Bar: 25 µm).
Table 2. Evaluation of the PrPd presence in PPs from PrPd-inoculated animals at different timepoints.
dpi 15 35 45 60 75 90 105 120 150 180 210 240 270
Positive/examined 0/6 0/6 0/6 4/6 6/6 6/6 6/6 6/6 6/6 6/6 6/6 4/4a 4/4a
Average intensity of PrPd depositionb 0 0 0 1 1 1 1.16 1.5 1.83 2.16 1.5 1 1.25
a: PrPd presence was only examined in Peyer’s patches of four animals due to the absence of this structure in sections of the other two animals from
the group of sacrifice. b: Average intensity is shown as a mean of the presence of PrPd in individual animals, evaluated semiquantitatively as follows: 0
(none); 1 (scarce); 2 (moderate); 3 (abundant).
intraepithelial macrophages was detected in infected
animals from the start of the experiment, peaking at 15
dpi. Thenceforth, a slight and progressive decrease in the
number of positive macrophages was observed until the
end of the experiment. However, the number of Mac-3-
positive intraepithelial macrophages remained
significantly higher than in control mice until 150 dpi
(Table 4, Fig. 2A).
The number of Mac-3-positive macrophages in the
lamina propria/submucosa of infected mice was
significantly higher than in controls throughout the
experiment. Mac-3 positive macrophage numbers
increased significantly from 15 dpi, peaking at 75 dpi;
thereafter, a progressive decrease in numbers was
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Fig 3. Proinflammatory cytokine production in the different evaluated
tissues. A. Immunohistochemical detection of TNF-α posit ive
intraepithelial macrophages (IHC, 120 dpi, Bar: 25 µm). B. TNF-α positive
cells located in epithelium and lamina propria of the intestine (IHC, 90 dpi,
Bar: 25 µm). C. Presence of TNF-α-expressing macrophages inside PPs
(IHC, 105 dpi, Bar: 25 µm). D. Intraepithelial macrophages reactives
against IL-α (IHC, 105 dpi, Bar: 25 µm). E. Macrophages expressing IL-6
in epithelium and lamina propria of the intestine (IHC, 150 dpi, Bar: 25
µm).
observed until 180 dpi (Table 4, Fig. 2B). Thenceforth,
the number of positive macrophages showed a slight
increase until the end of the experiment. 
Finally, in PPs lymphoid follicles, changes in Mac-
3-positive macrophage numbers mirrored those observed
in the lamina propria/submucosa of infected mice. The
number of labelled macrophages peaked at 75 dpi,
decreasing gradually thereafter until 180 dpi and
thereafter increasing slightly until the end of the
experiment (Table 4, Fig. 2C). The number of Mac-3-
positive macrophages within PPs lymphoid follicles was
considerably higher than in lamina propria/submucosa
throughout the experiment.
Cytokine dynamics in the intestine
In order to determine whether immunocompetent
cells might be involved in an inflammatory and immune
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Table 3. Sequential detection of PrPd in the different studied areas and appearing of clinical signs.






c No detection; g Detection
Table 4. Evolution in the number of reactive macrophages in inoculated (upper line) and control animals (left column).
Mac-3 Epithelium 15 dpi 35 dpi 45 dpi 60 dpi 75 dpi 90 dpi 105 dpi 120 dpi 150 dpi 180 dpi 210 dpi 240 dpi 270 dpi
(Mean±SD) 1.52±0.84 1.47±0.53 0.92±0.45 0.99±0.38 1.19±0.51 0.63±0.28 0.48±0.29 0.67±0.28 0.56±0.26 0.4±0.2 0.3±0.23 0.33±0.31 0.36±0.42
0 dpi NI (0.32±0.22) *** *** *** *** *** *** * *** *** ns ns ns ns
NBI (0.31±0.24) *** *** *** *** *** *** * *** *** ns ns ns ns
35 dpi NI (0.35±0.25) *** *** *** *** *** *** * *** *** ns ns ns ns
NBI (0.34±0.24) *** *** *** *** *** *** * *** *** ns ns ns ns
90 dpi NI (0.29±0.19) *** *** *** *** *** *** * *** *** ns ns ns ns
NBI (0.3±0.2) *** *** *** *** *** *** * *** *** ns ns ns ns
270 dpi NI (0.33±0.23) *** *** *** *** *** *** * *** *** ns ns ns ns
NBI (0.35±0.25 *** *** *** *** *** *** * *** *** ns ns ns ns
Mac-3 LP/SM 15 dpi 35 dpi 45 dpi 60 dpi 75 dpi 90 dpi 105 dpi 120 dpi 150 dpi 180 dpi 210 dpi 240 dpi 270 dpi
(Mean±SD) 0.55±0.31 1.23±0.48 2.32±0.91 3.14±0.91 6.55±1.91 4.13±1.66 2.98±1.11 4.84±1.58 3.74±1.56 2.88±1.19 3.41±2.08 3.63±1.60 3.94±2.03
0 dpi NI (0.26±0.38) ** *** *** *** *** *** *** *** *** *** *** *** ***
NBI (0.25±0.37) ** *** *** *** *** *** *** *** *** *** *** *** ***
35 dpi NI (0.29±0.41) ** *** *** *** *** *** *** *** *** *** *** *** ***
NBI (0.28±0.4) ** *** *** *** *** *** *** *** *** *** *** *** ***
90 dpi NI (0.23±0.35) ** *** *** *** *** *** *** *** *** *** *** *** ***
NBI (0.24±0.36) ** *** *** *** *** *** *** *** *** *** *** *** ***
270 dpi NI (0.27±0.39) ** *** *** *** *** *** *** *** *** *** *** *** ***
NBI (0.29±0.41) ** *** *** *** *** *** *** *** *** *** *** *** ***
Mac-3 PPs 15 dpi 35 dpi 45 dpi 60 dpi 75 dpi 90 dpi 105 dpi 120 dpi 150 dpi 180 dpi 210 dpi 240 dpi 270 dpi
(Mean±SD) 8.2±8.67 19.85±8.47 9.75±5.80 17.57±14.61 32.16±13.34 25.8±10.18 27.4±11.26 27.33±5.50 22.81±9.57 19.7±9.34 23.66±16.25 21±12 22±14
0 dpi NI (5±3) ns ** *** * *** ** ** * *** *** * * *
NBI (5±4) ns ** *** * *** ** ** * *** *** * * *
35 dpi NI (6±4) ns ** *** * *** ** ** * *** *** * * *
NBI (4±2) ns ** *** * *** ** ** * *** *** * * *
90 dpi NI (4±2) ns ** *** * *** ** ** * *** *** * * *
NBI (6±4) ns ** *** * *** ** ** * *** *** * * *
270 dpi NI (4±2) ns ** *** * *** ** ** * *** *** * * *
NBI (6±4) ns ** *** * *** ** ** * *** *** * * *
Differences from controls (NI, non inoculated and NBI, normal brain inoculated at 0, 35, 90 and 270 dpi) were considered statistically significant (*:
P<0.05; **: P<0.01; and ***: P<0.001 for student-t test or †, P<0.05; ††, P<0.01; and †††, P<0.001 from Mann-Whitney’s-U test).
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Fig. 4. Production of cytokines related with Th1/Th2 immune response in the structures studied. A. Presence of positive immunoreaction in
intraepithelial cells against IL-10 (IHC, 150 dpi, Bar: 25 µm). B. IFN-γ expressing-cell infiltrated in the epithelium (IHC, 180 dpi, Bar: 25 µm).
Table 5. Evolution in the number of reactive cells against TNF-α in inoculated (upper line) and control animals (left column).
TNF-α Epithelium 15 dpi 35 dpi 45 dpi 60 dpi 75 dpi 90 dpi 105 dpi 120 dpi 150 dpi 180 dpi 210 dpi 240 dpi 270 dpi
(Mean±SD) 1.84±0.68 1.32±0.62 1.45±0.64 0.4±0.36 0.85±0.43 0.94±0.43 1.56±0.81 1.44±0.63 1.72±0.61 1.36±0.49 1.98±0.67 1.81±0.64 1.72±1.13
0 dpi NI (1.32±0.69) ** ns ns *** ** * ns ns * ns ** * ns
NBI (1.33±0.71) ** ns ns *** ** * ns ns * ns ** * ns
35 dpi NI (1.35±0.72) ** ns ns *** ** * ns ns * ns ** * ns
NBI (1.34±0.71) ** ns ns *** ** * ns ns * ns ** * ns
90 dpi NI (1.29±0.66) ** ns ns *** ** * ns ns * ns ** * ns
NBI (1.3±0.67) ** ns ns *** ** * ns ns * ns ** * ns
270 dpi NI (1.33±0.7) ** ns ns *** ** * ns ns * ns ** * ns
NBI (1.35±0.72) ** ns ns *** ** * ns ns * ns ** * ns
TNF-α LP/SM 15 dpi 35 dpi 45 dpi 60 dpi 75 dpi 90 dpi 105 dpi 120 dpi 150 dpi 180 dpi 210 dpi 240 dpi 270 dpi
(Mean±SD) 1.59±0.5 1.19±0.45 1.03±0.57 0.33±0.32 0.71±0.29 1.08±0.46 1.29±0.41 1.12±0.59 1.68±0.58 1.13±0.6 1.1±0.44 1.22±0.66 1.4±1.15
0 dpi NI (1.52±0.85) ns ns * *** *** * ns ns ns ns * ns ns
NBI (1.53±0.85) ns ns * *** *** * ns ns ns ns * ns ns
35 dpi NI (1.55±0.88) ns ns * *** *** * ns ns ns ns * ns ns
NBI (1.54±0.87) ns ns * *** *** * ns ns ns ns * ns ns
90 dpi NI (1.49±0.82) ns ns * *** *** * ns ns ns ns * ns ns
NBI (1.5±0.83) ns ns * *** *** * ns ns ns ns * ns ns
270 dpi NI (1.53±0.86) ns ns * *** *** * ns ns ns ns * ns ns
NBI (1.55±0.88) ns ns * *** *** * ns ns ns ns * ns ns
TNF-α PPs 15 dpi 35 dpi 45 dpi 60 dpi 75 dpi 90 dpi 105 dpi 120 dpi 150 dpi 180 dpi 210 dpi 240 dpi 270 dpi
(Mean±SD) 0.25±0.5 0±0 0±0 0±0 0±0 0.3±0.67 0.6±1.34 0.25±0.5 0.33±0.81 0±0 0±0 0.12±0.25 0.25±0.5
0 dpi NI (0.12±0.25) ns ns ns ns ns † † ns † ns ns ns ns
NBI (0.13±0.28) ns ns ns ns ns † † ns † ns ns ns ns
35 dpi NI (0.15±0.28) ns ns ns ns ns † † ns † ns ns ns ns
NBI (0.14±0.27) ns ns ns ns ns † † ns † ns ns ns ns
90 dpi NI (0.09±0.22) ns ns ns ns ns † † ns † ns ns ns ns
NBI (0.1±0.23) ns ns ns ns ns † † ns † ns ns ns ns
270 dpi NI (0.13±0.26) ns ns ns ns ns † † ns † ns ns ns ns
NBI (0.15±0.28) ns ns ns ns ns † † ns † ns ns ns ns
Differences from controls (NI, non inoculated and NBI, normal brain inoculated at 0, 35, 90 and 270 dpi) were considered statistically significant (*:
P<0.05; **: P<0.01; and ***: P<0.001 for student-t test or †, P<0.05; ††, P<0.01; and †††, P<0.001 from Mann-Whitney’s-U test).
response against PrPd at natural entry sites, cytokines
with proinflammatory activity (TNF-α, IL-1α and IL-6)
as well as other cytokines (IFN-γ and IL-10) involved in
the cell-mediated immune response (Th1-Th2) were
evaluated by immunohistochemical methods.
a) Proinflammatory cytokines
TNF-α was the main cytokine detected in cells
located in the epithelium and lamina propria/submucosa
of infected animals, whereas IL-1α was the main
cytokine observed in mononuclear cells within PPs
lymphoid follicles. 
TNF-α-positive cells were mainly identified as
macrophages, although some positive lymphocytes were
occasionally observed. Changes in the number of
positive cells in epithelium and lamina propria/
submucosa were similar throughout the experiment. The
number of intraepithelial macrophages producing TNF-α
displayed a significant increase with respect to controls
at 15 dpi. Thereafter the number of cells producing this
cytokine decreased gradually in the epithelium as well as
in the lamina propria/submucosa, with numbers
significantly lower than those of controls between 45
and 90 dpi. The number of TNF-α positive cells in these
areas reached the lowest levels at 60 dpi (Table 5. Fig.
3A,B). From 105 dpi onwards, there was a progressive
increase in the number of positive cells. However, in the
lamina propria/submucosa, the number of TNF-α
positive cells was lower than, or similar to, that recorded
in control mice, while in the epithelium the presence of
TNF-α positive cells was significantly higher than in
controls during the final stage of the experiment (210-
240 dpi). Production of TNF-α in PPs lymphoid follicles
was very scarce throughout the experiment (Table 5, Fig.
3C). No expression of this cytokine was observed
between 35 and 75 dpi or between 180 and 210 dpi,
values being significantly lower than in controls. 
The number of IL-1α positive cells, mainly
macrophages, was scarce in epithelium and lamina
propria/submucosa from disease onset. These cells
displayed significantly lower values than controls
between 35 and 90 dpi and from 150 dpi to the end of
the experiment (Table 6; Fig. 3D). However, in PPs
1033
Cytokine dynamics in scrapie-infected mice
Table 6. Evolution in the number of reactive cells against IL-1α in inoculated (upper line) and control animals (left column).
IL-1α Epithelium 15 dpi 35 dpi 45 dpi 60 dpi 75 dpi 90 dpi 105 dpi 120 dpi 150 dpi 180 dpi 210 dpi 240 dpi 270 dpi
(Mean±SD) 0.84±0.45 0.33±0.22 0.65±0.47 0.4±0.4 0.81±0.36 0.54±0.31 0.69±0.37 0.74±0.55 0.38±0.34 0.36±0.34 0.3±0.29 0.27±0.27 0.28±0.45
0 dpi NI (0.78±0.39) ns *** ns ** ns * ns ns *** *** *** *** ***
NBI (0.79±0.4) ns *** ns ** ns * ns ns *** *** *** *** ***
35 dpi NI (0.81±0.42) ns *** ns ** ns * ns ns *** *** *** *** ***
NBI (0.8±0.41) ns *** ns ** ns * ns ns *** *** *** *** ***
90 dpi NI (0.75±0.36) ns *** ns ** ns * ns ns *** *** *** *** ***
NBI (0.76±0.37) ns *** ns ** ns * ns ns *** *** *** *** ***
270 dpi NI (0.79±0.4) ns *** ns ** ns * ns ns *** *** *** *** ***
NBI (0.81±0.42) ns *** ns ** ns * ns ns *** *** *** *** ***
IL-1α LP/SM 15 dpi 35 dpi 45 dpi 60 dpi 75 dpi 90 dpi 105 dpi 120 dpi 150 dpi 180 dpi 210 dpi 240 dpi 270 dpi
(Mean±SD) 0.83±0.41 0.35±0.2 0.42±0.35 0.35±0.34 0.4±0.29 0.41±0.3 0.67±0.33 0.44±0.29 0.56±0.32 0.56±0.31 0.16±0.28 0.19±0.26 0.24±0.52
0 dpi NI (0.8±0.37) ns *** *** *** *** *** ns *** * * *** *** ***
NBI (0.79±0.38) ns *** *** *** *** *** ns *** * * *** *** ***
35 dpi NI (0.81±0.42) ns *** *** *** *** *** ns *** * * *** *** ***
NBI (0.8±0.41) ns *** *** *** *** *** ns *** * * *** *** ***
90 dpi NI (0.75±0.36) ns *** *** *** *** *** ns *** * * *** *** ***
NBI (0.76±0.37) ns *** *** *** *** *** ns *** * * *** *** ***
270 dpi NI (0.79±0.4) ns *** *** *** *** *** ns *** * * *** *** ***
NBI (0.81±0.42) ns *** *** *** *** *** ns *** * * *** *** ***
IL-1α PPs 15 dpi 35 dpi 45 dpi 60 dpi 75 dpi 90 dpi 105 dpi 120 dpi 150 dpi 180 dpi 210 dpi 240 dpi 270 dpi
(Mean±SD) 0.25±0.5 1±2.44 0±0 0±0 0.36±0.92 1.33±3.31 0.25±0.46 0.66±1.15 0.6±1.34 0.08±0.28 0±0 0±0 0±0
0 dpi NI (0±0) † † ns ns † † † † † ns ns ns ns
NBI (0±0) † † ns ns † † † † † ns ns ns ns
35 dpi NI (0±0) † † ns ns † † † † † ns ns ns ns
NBI (0±0) † † ns ns † † † † † ns ns ns ns
90 dpi NI (0±0) † † ns ns † † † † † ns ns ns ns
NBI (0±0) † † ns ns † † † † † ns ns ns ns
270 dpi NI (0±0) † † ns ns † † † † † ns ns ns ns
NBI (0±0) † † ns ns † † † † † ns ns ns ns
Differences from controls (NI, non inoculated and NBI, normal brain inoculated at 0, 35, 90 and 270 dpi) were considered statistically significant (*:
P<0.05; **: P<0.01; and ***: P<0.001 for student-t test or †, P<0.05; ††, P<0.01; and †††, P<0.001 from Mann-Whitney’s-U test).
lymphoid follicles there was a significant increase in IL-
1α production during the initial stages (15 and 35 dpi),
followed by an absence of reactive cells between 45 and
60 dpi and by a significant increase from 75 to 150 dpi.
The presence of IL-6 positive cells (mainly
macrophages) in epithelium and lamina propria/
submucosa was also scarce from the start of the
experiment. Positive-cell numbers were similar to, or
significantly lower than, those recorded in control
animals between 15 at 90 dpi (Table 7; Fig. 3E).
However, from 105 dpi, a significant increase in positive
cell numbers was detected, lasting until the end of the
experiment. In PPs lymphoid follicles, numbers were
significantly lower than in controls from 15 dpi onwards,
reaching minimum levels at 35, 60, 150 and 210 dpi. 
b) Th1/Th2 immune response-associated cytokines
The presence of IFN-γ -cytokine immunolabelled
cells, mainly produced by T-lymphocytes during the Th1
immune response, and of IL-10 produced during the Th2
immune response, was scarce in epithelium and lamina
propria/submucosa (Tables 8, 9; Fig. 4A,B). A
significant increase in IFN-γ production was noted in
these locations during the initial stages of the
experiment, together with a significant drop in the
number of IL-10 positive cells between 15 and 90 dpi.
From 15 dpi until the end of the experiment, a
progressive decrease in the number of IFN-Á positive
cells was observed within PPs lymphoid follicles,
numbers being significantly lower than those recorded in
controls. The presence of IFN-γ positive cells reached
minimum levels between 105 and 120 dpi, when no
reactive cells were detected. Moreover, the presence of
IL-10 positive cells in PP lymphoid follicles had
significantly lower values than in controls throughout
the experiment.
Discussion
The results obtained here suggest that macrophages
may play a role in the uptake and transport of PrPd from
the intestinal lumen to underlying lymphoid tissues
following experimental oral inoculation. Furthermore,
there may be an early impairment of the local immune
response, as a result of which the inhibition of
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Table 7. Evolution in the number of reactive cells against IL-6 in inoculated (upper line) and control animals (left column).
IL-6 Epithelium 15 dpi 35 dpi 45 dpi 60 dpi 75 dpi 90 dpi 105 dpi 120 dpi 150 dpi 180 dpi 210 dpi 240 dpi 270 dpi
(Mean±SD) 0.15±0.16 0.1±0.14 0.42±0.26 0.29±0.24 0.2±0.2 0.4±0.35 1.04±0.75 0.82±0.45 0.89±0.38 0.47±0.27 0.7±0.75 0.51±0.39 0.44±0.5
0 dpi NI (0.31±0.2) ** *** ns ns * ns *** *** *** * * * ns
NBI (0.33±0.23) ** *** ns ns * ns *** *** *** * * * ns
35 dpi NI (0.35±0.25) ** *** ns ns * ns *** *** *** * * * ns
NBI (0.34±0.24) ** *** ns ns * ns *** *** *** * * * ns
90 dpi NI (0.29±0.19) ** *** ns ns * ns *** *** *** * * * ns
NBI (0.3±0.2) ** *** ns ns * ns *** *** *** * * * ns
270 dpiNI (0.33±0.23) ** *** ns ns * ns *** *** *** * * * ns
NBI (0.35±0.25) ** *** ns ns * ns *** *** *** * * * ns
IL-6 LP/SM 15 dpi 35 dpi 45 dpi 60 dpi 75 dpi 90 dpi 105 dpi 120 dpi 150 dpi 180 dpi 210 dpi 240 dpi 270 dpi
(Mean±SD) 0.41±0.34 0.22±0.19 0.53±0.32 0.52±0.36 0.44±0.3 0.59±0.35 1.36±0.46 0.97±0.51 1.45±0.6 0.72±0.35 1.05±0.63 0.92±0.43 0.86±0.68
0 dpi NI (0.52±0.28) ns *** ns ns ns ns *** *** *** * *** *** *
NBI (0.52±0.27) ns *** ns ns ns ns *** *** *** * *** *** *
35 dpi NI (0.55±0.31) ns *** ns ns ns ns *** *** *** * *** *** *
NBI (0.54±0.3) ns *** ns ns ns ns *** *** *** * *** *** *
90 dpi NI (0.49±0.25) ns *** ns ns ns ns *** *** *** * *** *** *
NBI (0.5±0.26) ns *** ns ns ns ns *** *** *** * *** *** *
270 dpiNI (0.53±0.29) ns *** ns ns ns ns *** *** *** * *** *** *
NBI (0.55±0.31) ns *** ns ns ns ns *** *** *** * *** *** *
IL-6 PPs 15 dpi 35 dpi 45 dpi 60 dpi 75 dpi 90 dpi 105 dpi 120 dpi 150 dpi 180 dpi 210 dpi 240 dpi 270 dpi
(Mean±SD) 1±1.73 0±0 0.83±2.04 0±0 0.88±1.83 1.5±2.17 1.23±1.23 1.11±1.26 0.16±0.57 0.5±0.96 0±0 1±1.4 2±2.91
0 dpi NI (2±2) † † † ns † † † † † † † † ns
NBI (2±2) † † † ns † † † † † † † † ns
35 dpi NI (3±3) † † † ns † † † † † † † † ns
NBI (3±3) † † † ns † † † † † † † † ns
90 dpi NI (1±1) † † † ns † † † † † † † † ns
NBI (2±2) † † † ns † † † † † † † † ns
270 dpiNI (2±2) † † † ns † † † † † † † † ns
NBI (3±3) † † † ns † † † † † † † † ns
Differences from controls (NI, non inoculated and NBI, normal brain inoculated at 0, 35, 90 and 270 dpi) were considered statistically significant (*:
P<0.05; **: P<0.01; and ***: P<0.001 for student-t test or †, P<0.05; ††, P<0.01; and †††, P<0.001 from Mann-Whitney’s-U test).
macrophages, immunocompetent cells with an important
role in inflammatory processes and in the immune
response, together with an alteration in the production of
cytokines involved in the modulation of these changes,
might impede the development of a specific local
immune response, favouring the accumulation and
subsequent spread of PrPd.
The mechanisms involved in the uptake and
transport of PrPd between intestinal wall structures and
lymphoid tissue have not been yet elucidated. Some
authors suggest that M cells may be involved in the
uptake of PrPd from the intestinal lumen (Beekes and
McBride, 2000; Heppner et al., 2001). Others report that
this protein is endocytosed by enterocytes, either via the
laminin receptor (Gauczynski et al., 2001) or via other
cotransport mechanisms (Mishra et al., 2004). For these
authors, the role of macrophages in these processes is
likely to be negligible. However, the fact that the number
of Mac-3-positive intraepithelial macrophages peaked at
early stages of the disease (15 dpi), and that a
disorganization of the microtubule network was
observed in macrophage cytoplasms from the initial
stages of the experiment – a finding also observed by
other authors (Nieznanski et al., 2006) – would support
the hypothesis that macrophages may play a role in the
transport of PrPd to PPs. In addition, the presence of
similar protein deposits in enterocytes suggests that
these cells may also be involved in PrPd internalization.
This hypothesis is further borne out by
immunohistochemical demonstration of the presence of
PrPd in enterocytes (Bons et al., 1999) and supports the
notion that gastrointestinal tract epithelial cells may
represent a possible target for prion entry and replication
(Pammer et al., 2000). Furthermore, the fact that
enterocytes may destroy material luminal uptaken
material in phagolysosomes, together with the ability of
macrophages to destroy small amounts of PrPd (Brun et
al., 2003; Maignien et al., 2005), would account for both
the infectious dose and the subsequent kinetics of the
infection, as well as explaining the individual variations
observed between different animals. Recent studies have
demonstrated that PrPd is readily digested by alimentary
tract fluids in sheep (Jeffrey et al., 2006) and that
animals could shed a small amount of the perorally
inoculated PrPd in the faeces (Krüger et al., 2009). Both
mechanisms could also contribute to individual
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Table 8. Evolution in the number of reactive cells against IL-10 in inoculated (upper line) and control animals (left column).
IL-10 Epithelium 15 dpi 35 dpi 45 dpi 60 dpi 75 dpi 90 dpi 105 dpi 120 dpi 150 dpi 180 dpi 210 dpi 240 dpi 270 dpi
(Mean±SD) 0.16±0.17 0.25±0.28 0.39±0.24 0.16±0.16 0.12±0.16 0.3±0.27 0.47±0.37 0.5±0.34 0.52±0.27 0.47±0.32 0.17±0.17 0.26±0.29 0.4±0.59
0 dpi NI (0.34±0.27) ** ns ns ** ** ns ns ns * ns * ns ns
NBI (0.34±0.28) ** ns ns ** ** ns ns ns * ns * ns ns
35 dpi NI (0.35±0.25) ** ns ns ** ** ns ns ns * ns * ns ns
NBI (0.34±0.24) ** ns ns ** ** ns ns ns * ns * ns ns
90 dpi NI (0.29±0.19) ** ns ns ** ** ns ns ns * ns * ns ns
NBI (0.3±0.2) ** ns ns ** ** ns ns ns * ns * ns ns
270 dpi NI (0.33±0.23) ** ns ns ** ** ns ns ns * ns * ns ns
NBI (0.35±0.25) ** ns ns ** ** ns ns ns * ns * ns ns
IL-10 LP/SM 15 dpi 35 dpi 45 dpi 60 dpi 75 dpi 90 dpi 105 dpi 120 dpi 150 dpi 180 dpi 210 dpi 240 dpi 270 dpi
(Mean±SD) 0.53±0.3 0.45±0.28 0.51±0.36 0.39±0.32 0.24±0.2 0.5±0.3 0.58±0.29 0.56±0.33 0.87±0.47 0.48±0.4 0.43±0.3 0.35±0.23 0.32±0.4
0 dpi NI (0.68±0.34) ns * ns ** *** * ns ns ns ns ** *** **
NBI (0.67±0.32) ns * ns ** *** * ns ns ns ns ** *** **
35 dpi NI (0.71±0.37) ns * ns ** *** * ns ns ns ns ** *** **
NBI (0.7±0.36) ns * ns ** *** * ns ns ns ns ** *** **
90 dpi NI (0.65±0.31) ns * ns ** *** * ns ns ns ns ** *** **
NBI (0.66±0.32) ns * ns ** *** * ns ns ns ns ** *** **
270 dpi NI (0.69±0.35) ns * ns ** *** * ns ns ns ns ** *** **
NBI (0.69±0.35) ns * ns ** *** * ns ns ns ns ** *** **
IL-10 PPs 15 dpi 35 dpi 45 dpi 60 dpi 75 dpi 90 dpi 105 dpi 120 dpi 150 dpi 180 dpi 210 dpi 240 dpi 270 dpi
(Mean±SD) 0±0 0.08±0.28 0.12±0.34 0±0 0±0 0±0 0±0 0.2±0.44 0.08±0.28 0±0 0±0 0.12±0.25 0.25±0.5
0 dpi NI (0.64±1.33) ns † † ns ns ns ns † † ns ns † †
NBI (0.65±1.32) ns † † ns ns ns ns † † ns ns † †
35 dpi NI (0.67±1.36) ns † † ns ns ns ns † † ns ns † †
NBI (0.66±1.35) ns † † ns ns ns ns † † ns ns † †
90 dpi NI (0.61±1.3) ns † † ns ns ns ns † † ns ns † †
NBI (0.62±1.31) ns † † ns ns ns ns † † ns ns † †
270 dpi NI (0.65±1.34) ns † † ns ns ns ns † † ns ns † †
NBI (0.67±1.36) ns † † ns ns ns ns † † ns ns † †
Differences from controls (NI, non inoculated and NBI, normal brain inoculated at 0, 35, 90 and 270 dpi) were considered statistically significant (*:
P<0.05; **: P<0.01; and ***: P<0.001 for student-t test or †, P<0.05; ††, P<0.01; and †††, P<0.001 from Mann-Whitney’s-U test).
variations and to infection kinetics. 
From 60 dpi, accumulation of PrPd was observed in
phagocytic and antigen-presenting cells in PPs, together
with an increase in the number of Mac-3-positive
macrophages within these lymphoid structures, which
peaked at 75 dpi. There is thus a clear spatial and
temporal link between the presence of PrPd and changes
in the number of macrophages in the intestinal structures
studied, suggesting that macrophages may be involved in
the spread of PrPd from intestinal epithelium to
lymphoid tissue. A number of authors have suggested
that some follicular dendritic cells may in fact be
migratory dendritic cells, which play a fundamental role
in the transport and accumulation of PrPd from the
intestinal lumen to lymphoid tissues (Huang et al., 2002;
Beekes and McBride, 2007; Glaysher and Mabbott,
2007; Raymond et al., 2007); however, these studies
evaluated neither the migratory capacity of macrophages
nor their potential role in the spread of the pathogenic
agent. The results obtained here do not rule out the role
of migratory dendritic cells in the uptake and transport
of the PrPd, but point to macrophages as an additional
participant in these processes.
Macrophages may have been recruited initially to
destroy the PrPd as part of the innate local immune
response (Brun et al., 2003; Maignien et al., 2005); this
mechanism would be similar in nature to the
chemoattraction of migratory dendritic cells by certain
prion protein fragments (Kaneider et al., 2003) and
might supply a means of transporting PrPd throughout
the organism. This hypothesis was borne out here by the
progressive decrease observed in the number of Mac-3-
positive macrophages in the structures studied from the
initial stages of the experiment until 180 dpi. At this
timepoint, PrPd accumulation in follicular dendritic cells
and tingible body macrophages in PPs had already
peaked. Thus, the decrease in the number of
macrophages could point to a failed attempt by
macrophages to control the replication of the pathogenic
prion, enabling the subsequent spread of the PrPd to
other organs. 
Few studies have addressed the immune response in
TSEs, since it has long been accepted that these diseases
do not display the immune response typical of other
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Table 9. Evolution in the number of positive cells against IFN-γ in inoculated (upper line) and control animals (left column).
IFN-γ Epithelium 15 dpi 35 dpi 45 dpi 60 dpi 75 dpi 90 dpi 105 dpi 120 dpi 150 dpi 180 dpi 210 dpi 240 dpi 270 dpi
(Mean±SD) 0.1±0.15 0.14±0.23 0.04±0.1 0.07±0.14 0.06±0.11 0.06±0.08 0.17±0.18 0.06±0.12 0.05±0.1 0.05±0.1 0.16±0.24 0.08±0.14 0.02±0.1
0 dpi NI (0.01±0.05) †† †† ns ns ns † †† ns ns ns ns ns ns
NBI (0.01±0.05) †† †† ns ns ns † †† ns ns ns ns ns ns
35 dpi NI (0.01±0.05) †† †† ns ns ns † †† ns ns ns ns ns ns
NBI (0.01±0.05) †† †† ns ns ns † †† ns ns ns ns ns ns
90 dpi NI (0.01±0.05) †† †† ns ns ns † †† ns ns ns ns ns ns
NBI (0.01±0.05) †† †† ns ns ns † †† ns ns ns ns ns ns
270 dpi NI (0.01±0.05) †† †† ns ns ns † †† ns ns ns ns ns ns
NBI (0.01±0.05) †† †† ns ns ns † †† ns ns ns ns ns ns
IFN-γ LP/SM 15 dpi 35 dpi 45 dpi 60 dpi 75 dpi 90 dpi 105 dpi 120 dpi 150 dpi 180 dpi 210 dpi 240 dpi 270 dpi
(Mean±SD) 0.18±0.18 0.15±0.15 0.08±0.14 0.13±0.18 0.06±0.09 0.1±0.13 0.17±0.27 0.16±0.24 0.06±0.14 0.08±0.11 0.26±0.36 0.08±0.14 0.04±0.13
0 dpi NI (0.04±0.08) †† †† ns ns ns ns ns ns ns ns †† ns ns
NBI (0.05±0.1) †† †† ns ns ns ns ns ns ns ns †† ns ns
35 dpi NI (0.05±0.09) †† †† ns ns ns ns ns ns ns ns †† ns ns
NBI (0.05±0.1) †† †† ns ns ns ns ns ns ns ns †† ns ns
90 dpi NI (0.04±0.08) †† †† ns ns ns ns ns ns ns ns †† ns ns
NBI (0.04±0.06) †† †† ns ns ns ns ns ns ns ns †† ns ns
270 dpi NI (0.05±0.08) †† †† ns ns ns ns ns ns ns ns †† ns ns
NBI (0.05±0.1) †† †† ns ns ns ns ns ns ns ns †† ns ns
IFN-γ PPs 15 dpi 35 dpi 45 dpi 60 dpi 75 dpi 90 dpi 105 dpi 120 dpi 150 dpi 180 dpi 210 dpi 240 dpi 270 dpi
(Mean±SD) 0.66±0.57 2.18±2.31 1.33±2.38 0.6±1.26 0.07±0.27 1.11±1.45 0±0 0±0 0.81±0.87 0.52±0.87 1.33±1.96 1.3±2.2 1.25±2.5
0 dpi NI (2.44±2.83) † ns † † † † ns ns † † † † †
NBI (2.44±2.83) † ns † † † † ns ns † † † † †
35 dpi NI (2.47±2.86) † ns † † † † ns ns † † † † †
NBI (2.46±2.85) † ns † † † † ns ns † † † † †
90 dpi NI (2.41±2.8) † ns † † † † ns ns † † † † †
NBI (2.42±2.81) † ns † † † † ns ns † † † † †
270 dpi NI (2.5±2.87) † ns † † † † ns ns † † † † †
NBI (2.47±2.86) † ns † † † † ns ns † † † † †
Differences from controls (NI, non inoculated and NBI, normal brain inoculated at 0, 35, 90 and 270 dpi) were considered statistically significant (*:
P<0.05; **: P<0.01; and ***: P<0.001 for student-t test or †, P<0.05; ††, P<0.01; and †††, P<0.001 from Mann-Whitney’s-U test).
infectious processes (Aguzzi et al., 2003). These studies,
focussing mainly on the CNS, have demonstrated
microglial activation, evident both in increased cytokine
gene transcription and in the production of IL-1, IL-6,
IFN-γ, IL-10 and TNF-α under certain circumstances
(Veerhuis et al., 2002; Baker and Manuelidis, 2003;
Thackray et al., 2004). However, little is known about
the in vivo role of the chemical mediators produced by
different immune-system cells at the entry sites for PrPd
following oral infection.
The Th1 immune response is characterized by
increased production of cytokines such as IFN-γ,
induced by TNF-α and IL1-γ (Samuel, 2001; Abbas and
Litchman, 2004). The present results showed a
significant increase in macrophage TNF-α production,
coinciding with maximum intraepithelial macrophage
numbers at 15 dpi, suggesting a possible anti-PrPd local
inflammatory response mechanism. However, this was
not accompanied by an increase in IL-1α production,
and few IFN-γ -reactive cells were observed.
Afterwards, and despite the highly-significant increase
in macrophage numbers detected in lamina propria/
submucosa between 60 and 75 dpi, a marked decrease
was observed in macrophage synthesis of
proinflammatory chemical mediators, mainly TNF-α,
which reached minimum values at this stage. This
decrease may be related to increased production of IL-
10, a cytokine which inhibits the maturation of antigen-
presenting cells and the production of proinflammatory
cytokines (Abbas and Litchman, 2004). However, no
significant increase was noted here in the number of IL-
10 positive cells, which would rule out its involvement
in a hypothetical inhibition mechanism. Thus, the
present results appear to support a possible role of PrPd
as an inhibitor of the local immune response, since, as
occurs in other infectious processes in which direct
action of the agent on immunocompetent cells impairs
cell function (Rahman and McFadden, 2006; Winthrop,
2006; Wilson and Crabtree, 2007), the accumulation of
PrPd in macrophages would inhibit their capacity to
synthesize chemical mediators. Moreover, following
PrPd detection in PPs at 60 dpi, some recovery of TNF-
α production in lamina propria and submucosa was
observed. This finding supports the hypothesis that the
local immune response in lamina propria and submucosa
may be inhibited during the transport of PrPd to PPs, and
that this response may be restored once PrPd is located
in PPs. The absence of a significant increase in TNF-α
levels in lymphoid follicles further suggests that
inhibition of the local immune response may take place
at both the transit and accumulation sites, thus favouring
the spread of PrPd to other areas.
From the onset of the disease, there was a
progressive decrease in the number of IFN-γ-reactive
cells in PPs, which reached minimum values between
60-75 dpi, coinciding with the detection of PrPd in these
locations. This decrease may be evidence of a functional
impairment of T lymphocytes, the main producers of
IFN-γ , and thus of the macrophage/lymphocyte
costimulation mechanism required to induce an adequate
cellular immune response (Abbas and Litchman, 2004;
Schoenborn and Wilson, 2007). The possible inhibition
of the Th1 response, together with the macrophage
chemotaxis reported earlier, could be a key element in
the transport of PrPd to the lymphoid tissue. The lack of
local inflammatory response in transit and accumulation
sites would facilitate the accumulation and subsequent
spread of PrPd to the intestinal nerve plexuses, and
thence to the brain, a progression confirmed by
sequential detection of PrPd in these sites and also
reported in other studies of the neural spread of PrPd
(Beekes and McBride, 2000; Van Keulen et al., 2000).
The Th2 immune response is characterized by the
predominant production of IL-6 and IL-10. On the other
hand, the absence of TNF-α and IL-1γ prevents the
appropriate stimulation of IL-6-producing cells (Abbas
and Litchman, 2004). The results obtained here show
that this absence coincided with a lack of IL-10-reactive
cells. Thus, the normal development of processes
leading to the establishment of a Th2 response would be
impeded. Th1 and Th2 immune responses would be
affected in the course of the disease and this would allow
both the accumulation of PrPd in antigen-presenting
cells and the impairment of the microenvironment
required for the correct stimulation of T and B
lymphocytes. However, further research is required to
confirm this hypothesis and to study in depth the exact
nature of this mechanism.
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